Table 5.
Histological grade and effectiveness of treatment in patients with acute GI GVHD.
| GVHD grade | No treatment or BDP | +FK, PSL, and mPSL | +ATG and infliximab | Total |
|---|---|---|---|---|
| Grade I | 100% (19/19) | 87.0% (20/23) | 90.0% (9/10) | 92.3% (48/52) |
| Grade II | 100% (9/9) | 88.2% (15/17) | 70.0% (7/10) | 86.1% (31/36) |
| Grade III | 87.5% (7/8) | 90.5% (19/21) | 62.5% (10/16) | 80.0% (36/45) |
| Grade IV | 100.0% (3/3) | 44.4% (8/18) | 17.6% (3/17) | 36.8% (14/38) |
| Total | 97.4% (38/39) | 78.5% (62/79) | 54.7% (29/53) | 75.4% (129/171) |
BDP: beclometasone dipropionate; PSL: prednisolone; mPSL: methylprednisolone; ATG: antithymocyte globulin.